BION_2 was listed on 24 July 2023 by the blackbasta ransomware group (the group's claim; Ransomware Tracker by ExposureDrift has not confirmed a breach). blackbasta listed 6 organizations that month and 523 in total.
- Listed 1214 days ago.
- 904 organizations were listed by all groups in July 2023, see the month.
- 71 in Healthcare that month.
- 65 in US that month.
Updated 2026-11-19 06:49 UTC. Data: public leak-site listings. How we work.
Threat Group Post & Evidence
- Listed by
- Black Basta 523 listings in total
The listing states no data size and no ransom demand.
No capture of the original post
We only show a screenshot when we captured the group's own page ourselves. For this listing we have not, so none is shown.
The group's leak-site address is on paid plans
Free accounts see who listed this organization, when, and what the post claims. The address of the group's own page is shown to license-key holders. If you have a key, see what a license key adds.
What the group says it holds
Taken from the group's own post. Ransomware Tracker by ExposureDrift has not seen the data and cannot confirm any of this.
Launched in 2014, BionPharma was founded by a team of executives and professionals with years of cumulative experience in the generics industry. Bionpharma’s goals are to develop and commercialize affordable quality generics and building strong and effective partnerships. Based in Princeton, New Jersey, and with offices in Raleigh, North Carolina BionPharma is licensed to do business in the United States and is accomplished in the areas of product development, regulatory affairs, quality management, sales and distribution, and supply chain management. Today, Bionpharma is one of the largest suppliers of soft gel capsules in the US market with a strong presence in both the prescription and over-the-counter markets. Bionpharma enjoys a presence in all the pharmacy chains across the US market, with online presence for certain of our OTC products on AmazonSITE: https://www.bionpharma.com Add…
Show the full post (944 characters)
Launched in 2014, BionPharma was founded by a team of executives and professionals with years of cumulative experience in the generics industry. Bionpharma’s goals are to develop and commercialize affordable quality generics and building strong and effective partnerships. Based in Princeton, New Jersey, and with offices in Raleigh, North Carolina BionPharma is licensed to do business in the United States and is accomplished in the areas of product development, regulatory affairs, quality management, sales and distribution, and supply chain management. Today, Bionpharma is one of the largest suppliers of soft gel capsules in the US market with a strong presence in both the prescription and over-the-counter markets. Bionpharma enjoys a presence in all the pharmacy chains across the US market, with online presence for certain of our OTC products on AmazonSITE: https://www.bionpharma.com Address 400 Alexander Park Princeton, NJ 08540
Plain-English summary AI-written
The group says it holds information describing BionPharma, a generics company that supplies soft gel capsules and operates in the United States.
Written by an AI model (openai/gpt-6-luna) from the post above. It can contain mistakes: rely on the quote, not the summary.
What to do about this listing
Choose who you are. Each step shows why it appears and, where we have one, its source. General guidance, not legal or incident-response advice.
If you work with BION_2 (customer, supplier or partner)
Within 3 days
- Do not open the group's page or download the data Do not visit the leak site or download files from a listing. Holding stolen data can be unlawful, and the files can carry malware. Wait for the company's own notice. Why: A safety rule for any leak listing.
- Ask BION_2 directly Write to your contact and ask whether your data, or your access to their systems, is in scope, and ask for a written statement. Your contract or data-protection law may oblige them to tell you if your data is affected: check the notification clause. Why: A listing is only the group's claim; the company is the one who can confirm what was taken.
- Review what BION_2 can reach of yours List the accounts, API keys, VPN or SSO connections and shared mailboxes this company has with you. Rotate the keys you gave them and remove access they do not need. Why: Access a supplier holds is how a listing about them can become a problem for you.
Within 30 days
- Keep watching BION_2 A supplier's listing can change after the first sighting: the group can add data, change the status or publish. Add the company to your supplier list to be told, and check your own domain too. Why: A listing is a moving claim, not a single event. Add to your supplier list Check your own domain
If you are BION_2
Within 3 days
- Find out what was actually taken The post names no specific kind of data, so no data-specific steps are shown. Check the group's own post and your logs to learn what is claimed and what is real. Why: The listing text names no data types.
- Check regulatory and stakeholder notification duties United States: state breach-notification laws apply; listed companies may also have SEC Form 8-K Item 1.05 duties for material incidents, and HIPAA applies to health data. Health data adds sector rules. This is general guidance, not legal advice: confirm current rules with counsel. Why: Listing country: United States.
-
Check the ways blackbasta is reported to get in
Check these first; they are how the group is reported to work in general.
- Affiliates mainly use spearphishing; from February 2024 they also exploited ConnectWise CVE-2024-1709. (update of 8 Nov 2024)
- The November 2024 update adds a campaign of spam followed by calls and Microsoft Teams messages posing as IT support to get remote-access tools installed. (update of 8 Nov 2024)
General readiness for any ransomware claim (not about this listing)
- Offline, immutable backups and a restore drill Keep backups outside domain-admin reach and practise a restore; a leak does not remove the risk of re-encryption. Why: General practice for any ransomware claim; not specific to this listing.
- Look for mass file access and unusual outbound transfers Review EDR, proxy and identity logs for bulk reads, archive creation and large uploads to file-sharing services. Why: General practice for any ransomware claim; not specific to this listing.
- Phishing-resistant MFA on remote access Enforce MFA on VPN, SSO and admin panels, and retire password-only or SMS-based remote access. Why: General practice for any ransomware claim; not specific to this listing.
Listing details
Listing severity score (heuristic)
72/100 • ELEVATEDA heuristic built from sector, group, data volume and claim details. It is not evidence that a breach occurred or a measure of harm.
External Attack Surface Profile
ASM IntelligenceRun a free passive scan on your own domain to see what an attacker can see from the outside.